- Description
- Table of Contents
- Request Sample
The Global Cancer Registry Software market is expected to reach $112.5 million by 2026 growing at a CAGR of 11.2% during 2018 to 2026. A cancer registry is a computerized database that uses software solutions to arrange, collect, and store data on cancer patients to assess cancer-specific outcomes, conditions, and drug/medical device exposure. These solutions help store, manage, and provide access to information that helps in building a cancer patient registry. Factors such as growing prevalence of cancer & favourable government initiatives and growing adoption of EHRs are fueling the market growth. Though, privacy and data security-related concerns are restraining the market growth. By Type, Standalone Software segment has steady growth due to it provides useful and easy-to-use tools to store and process registry data and it offers advanced flexibility and features such as multiple system usage and automatic upgradation. The key vendors mentioned are Mckesson Corporation, Rocky Mountain Cancer Data Systems, C/Net Solutions and Elekta AB (PUB). Deployment Models Covered: • Cloud-Based Models • On-Premise Models Database Types Covered: • Public Databases • Commercial Databases Types Covered: • Integrated Software • Standalone Software Functionalities Covered: • Patient Care Management • Product Outcome Evaluation • Medical Research & Clinical Studies • Cancer Reporting to Meet State and Federal Regulations End Users Covered: • Hospitals & Medical Practices • Private Payers • Pharmaceutical, Biotechnology, and Medical Device Companies • Cancer Research Centers • Government Organizations & Third-Party Administrators • Other End Users Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cancer Registry Software Market, By Deployment Model
5.1 Introduction
5.2 Cloud-Based Models
5.3 On-Premise Models
6 Global Cancer Registry Software Market, By Database Type
6.1 Introduction
6.2 Public Databases
6.3 Commercial Databases
7 Global Cancer Registry Software Market, By Type
7.1 Introduction
7.2 Integrated Software
7.3 Standalone Software
8 Global Cancer Registry Software Market, By Functionality
8.1 Introduction
8.2 Patient Care Management
8.3 Product Outcome Evaluation
8.4 Medical Research & Clinical Studies
8.5 Cancer Reporting to Meet State and Federal Regulations
9 Global Cancer Registry Software Market, By End User
9.1 Introduction
9.2 Hospitals & Medical Practices
9.3 Private Payers
9.4 Pharmaceutical, Biotechnology, and Medical Device Companies
9.5 Cancer Research Centers
9.6 Government Organizations & Third-Party Administrators
9.7 Other End Users
10 Global Cancer Registry Software Market, By Geography
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 South America
10.5 Middle East & Africa
11 Strategic Benchmarking
12 Vendors Landscape
12.1 Mckesson Corporation
12.2 Rocky Mountain Cancer Data Systems
12.3 C/Net Solutions
12.4 Elekta AB (PUB)
List of Data Tables
1 Global Cancer Registry Software Market Outlook, By Region (2016-2026) ($MN)
2 Global Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) ($MN)
3 Global Cancer Registry Software Market Outlook, By Cloud-Based Models (2016-2026) ($MN)
4 Global Cancer Registry Software Market Outlook, By On-Premise Models (2016-2026) ($MN)
5 Global Cancer Registry Software Market Outlook, By Database Type (2016-2026) ($MN)
6 Global Cancer Registry Software Market Outlook, By Public Databases (2016-2026) ($MN)
7 Global Cancer Registry Software Market Outlook, By Commercial Databases (2016-2026) ($MN)
8 Global Cancer Registry Software Market Outlook, By Type (2016-2026) ($MN)
9 Global Cancer Registry Software Market Outlook, By Integrated Software (2016-2026) ($MN)
10 Global Cancer Registry Software Market Outlook, By Standalone Software (2016-2026) ($MN)
11 Global Cancer Registry Software Market Outlook, By Functionality (2016-2026) ($MN)
12 Global Cancer Registry Software Market Outlook, By Patient Care Management (2016-2026) ($MN)
13 Global Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2016-2026) ($MN)
14 Global Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2016-2026) ($MN)
15 Global Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2016-2026) ($MN)
16 Global Cancer Registry Software Market Outlook, By End User (2016-2026) ($MN)
17 Global Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2016-2026) ($MN)
18 Global Cancer Registry Software Market Outlook, By Private Payers (2016-2026) ($MN)
19 Global Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2016-2026) ($MN)
20 Global Cancer Registry Software Market Outlook, By Cancer Research Centers (2016-2026) ($MN)
21 Global Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2016-2026) ($MN)
22 Global Cancer Registry Software Market Outlook, By Other End Users (2016-2026) ($MN)
23 North America Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) ($MN)
24 North America Cancer Registry Software Market Outlook, By Database Type (2016-2026) ($MN)
25 North America Cancer Registry Software Market Outlook, By Type (2016-2026) ($MN)
26 North America Cancer Registry Software Market Outlook, By Functionality (2016-2026) ($MN)
27 North America Cancer Registry Software Market Outlook, By End User (2016-2026) ($MN)
28 Europe Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) ($MN)
29 Europe Cancer Registry Software Market Outlook, By Database Type (2016-2026) ($MN)
30 Europe Cancer Registry Software Market Outlook, By Type (2016-2026) ($MN)
31 Europe Cancer Registry Software Market Outlook, By Functionality (2016-2026) ($MN)
32 Europe Cancer Registry Software Market Outlook, By End User (2016-2026) ($MN)
33 Asia Pacific Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) ($MN)
34 Asia Pacific Cancer Registry Software Market Outlook, By Database Type (2016-2026) ($MN)
35 Asia Pacific Cancer Registry Software Market Outlook, By Type (2016-2026) ($MN)
36 Asia Pacific Cancer Registry Software Market Outlook, By Functionality (2016-2026) ($MN)
37 Asia Pacific Cancer Registry Software Market Outlook, By End User (2016-2026) ($MN)
38 South America Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) ($MN)
39 South America Cancer Registry Software Market Outlook, By Database Type (2016-2026) ($MN)
40 South America Cancer Registry Software Market Outlook, By Type (2016-2026) ($MN)
41 South America Cancer Registry Software Market Outlook, By Functionality (2016-2026) ($MN)
42 South America Cancer Registry Software Market Outlook, By End User (2016-2026) ($MN)
43 Middle East & Africa Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) ($MN)
44 Middle East & Africa Cancer Registry Software Market Outlook, By Database Type (2016-2026) ($MN)
45 Middle East & Africa Cancer Registry Software Market Outlook, By Type (2016-2026) ($MN)
46 Middle East & Africa Cancer Registry Software Market Outlook, By Functionality (2016-2026) ($MN)
47 Middle East & Africa Cancer Registry Software Market Outlook, By End User (2016-2026) ($MN)